Creon 00032-2636
Generic: Pancrelipase
Product NDC
00032-2636- Manufacturer
- Abbvie Inc.
- Dosage Form
- Capsule, Delayed Release Pellets
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- October 12, 2023
- Listing Expires
- December 31, 2026
- Application
- BLA020725
Need to source Creon? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pancrelipase Amylase | 120000 [USP'U]/1 |
| Pancrelipase Lipase | 24000 [USP'U]/1 |
| Pancrelipase Protease | 76000 [USP'U]/1 |
Packaging Options(3)
100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-2636-01)
24 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-2636-30)
240 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-2636-70)